After a year of many Americans putting off doctor visits and/or medical treatments, employers could be looking at a large bill. Health care costs are already estimated to increase by 5.3 percent in 2021, and employees and health plan members that are planning to seek treatment for deferred health care could drive employer expenses even higher.1
- 2 in 5 American are concerned that they may have an undiagnosed health condition2
- 31% of individuals with a chronic health condition say their health has gotten worse3
- 48% of the public say they skipped or postponed medical care4
Employees visited the doctor less, if at all. This likely means missed preventive screenings, skipped chronic care visits and delayed elective procedures. Virtual and telehealth visits attempted to address the gap in health care interactions, and some employers even ramped up wellness outreach. But there was still a significant amount of missed health care opportunities, and the cost impact is still unknown.
What can employers do now to prepare for the influx of health care claims and costs?
In the recent webinar, Insights Into the Impact of Deferred Health Care, we talked to Benefitfocus Health Insights Broker Customer Lead Amanda Johnson, and Benefitfocus Health Insights Employer Lead Wendie Carbone, for an inside look at the potential impact health care interruptions and the resulting cost. Watch and learn how employers and brokers are responding by using data analytics tools to:
- Gain actionable insights into health plan utilization trends
- Project the budgetary impact of deferred health care
- Inform and drive employer health plan strategy
- And more!
You may already be seeing the impacts of deferred care in your health plans costs today. However, you can take steps now to mitigate long-term effects in the future.
Speak to a Benefitfocus specialist about what you can do to be ready for the unknown.
1Rightway Health - Prepping for Post-Covid: How to lower costs for high-risk members
2Data is from a survey conducted online by The Harris Poll on behalf of Quest Diagnostics between November 10-12, 2020, among 2,050 US adults age 18+